Tru Hematology Test
Jan 2026
268d
Truvian Sciences, Inc. has submitted 1 FDA 510(k) premarket notifications since 2026, of which 1 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include Counter, Differential Cell . Use the specialty filter in the sidebar to narrow results.